EFFECTIVENESS OF L-ARGININE IN THE TREATMENT OF ERECTILE DYSFUNCTION WITH LONG-TERM USE

The aim of the study was to assess the effectiveness of L-arginine (Tivortin® aspartate by "Yuria-Pharm") in erectile dysfunction caused by endothelial dysfunction. The study involved 36 men aged 47 to 58 years, suffering from type 2 diabetes, stage I hypertension, obesity of stage I-II, dyslipidemia, and mild to moderate erectile dysfunction. The patients received intravenous infusions of Arginine hydrochloride (Tivortin® infusion solution) at a dose of 42 mg/ml, 100 ml for 5 days, followed by oral administration of L-Arginine aspartate (Tivortin® aspartate) 10 ml twice a day with meals for 60 days. The article presents data indicating the necessity of using L-arginine as monotherapy (Tivortin® aspartate), which has a positive effect on the severity of erections in patients with erectile dysfunction caused by endothelial dysfunction.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-25
DOI
https://doi.org/10.5281/zenodo.15082030
Primary Topic
Sexual function and dysfunction studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EFFECTIVENESS OF L-ARGININE IN THE TREATMENT OF ERECTILE DYSFUNCTION WITH LONG-TERM USE

Zenodo (CERN European Organization for Nuclear Research)
Sexual function and dysfunction studies
article

EFFECTIVENESS OF L-ARGININE IN THE TREATMENT OF ERECTILE DYSFUNCTION WITH LONG-TERM USE

article en

Abstract

The aim of the study was to assess the effectiveness of L-arginine (Tivortin® aspartate by "Yuria-Pharm") in erectile dysfunction caused by endothelial dysfunction. The study involved 36 men aged 47 to 58 years, suffering from type 2 diabetes, stage I hypertension, obesity of stage I-II, dyslipidemia, and mild to moderate erectile dysfunction. The patients received intravenous infusions of Arginine hydrochloride (Tivortin® infusion solution) at a dose of 42 mg/ml, 100 ml for 5 days, followed by oral administration of L-Arginine aspartate (Tivortin® aspartate) 10 ml twice a day with meals for 60 days. The article presents data indicating the necessity of using L-arginine as monotherapy (Tivortin® aspartate), which has a positive effect on the severity of erections in patients with erectile dysfunction caused by endothelial dysfunction.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 51%
Sexual function and dysfunction studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EFFECTIVENESS OF L-ARGININE IN THE TREATMENT OF ERECTILE DYSFUNCTION WITH LONG-TERM USE · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS